NRX Pharmaceuticals, Inc. Common Stock (NASDAQ: NRXP) last traded at $3.56, up 1.42% on the session. The quote above updates while this page is open; the figures below are drawn from NRX Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
NRX Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker NRXP. Its market capitalisation is $154.13 million.
Valuation measures for NRX Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $154.13M |
|---|---|
| Enterprise value | $161.78M |
| Price / sales | 42.65 |
| Beta | 2.02 |
Trailing-twelve-month figures tagged in NRX Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $3.61M |
|---|---|
| Net income (TTM) | -$23.48M |
| EPS (TTM) | -$0.500 |
| Operating margin | -550.47% |
| Cash | $26.69M |
Range and volume for NRXP over the past 52 weeks.
| 52-week high | $5.06 |
|---|---|
| 52-week low | $1.62 |
| Volume | 610.4K |
| Average volume | 1.25M |
| Previous close | $3.51 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.